Trial Profile
A Open-label, Radomized, Crossover Clinical Trial to Assess the Pharmacokinetics of Pregabalin CR After Multiple Dosing as Compared to Pregabalin IR in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Jul 2021
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary) ; Pregabalin
- Indications Neuropathic pain
- Focus Pharmacokinetics
- Sponsors Yuhan
- 10 Jul 2021 Results comparing the pharmacokinetics of pregabalin SR and immediate-release (IR) formulations after multiple oral doses in healthy individuals published in the Clinical Therapeutics
- 08 Nov 2016 Status changed from active, no longer recruiting to completed.
- 27 Jun 2016 Status changed from not yet recruiting to active, no longer recruiting.